FULGENT GENETICS ($FLGT) posted quarterly earnings results on Friday, August 1st. The company reported earnings of $0.07 per share, beating estimates of -$0.19 by $0.26. The company also reported revenue of $81,800,000, beating estimates of $77,729,436 by $4,070,564.
You can see Quiver Quantitative's $FLGT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
FULGENT GENETICS Insider Trading Activity
FULGENT GENETICS insiders have traded $FLGT stock on the open market 7 times in the past 6 months. Of those trades, 1 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $FLGT stock by insiders over the last 6 months:
- PAUL KIM (CFO and Treasurer) purchased 100,000 shares for an estimated $1,596,470
- JIAN XIE (President and COO) has made 0 purchases and 3 sales selling 3,008 shares for an estimated $61,498.
- HANLIN GAO (Chief Scientific Officer) has made 0 purchases and 3 sales selling 1,793 shares for an estimated $36,638.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
FULGENT GENETICS Hedge Fund Activity
We have seen 83 institutional investors add shares of FULGENT GENETICS stock to their portfolio, and 91 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 1,616,734 shares (-41.9%) from their portfolio in Q1 2025, for an estimated $27,322,804
- ACADIAN ASSET MANAGEMENT LLC added 446,076 shares (+124.0%) to their portfolio in Q1 2025, for an estimated $7,538,684
- MILLENNIUM MANAGEMENT LLC added 437,632 shares (+28.6%) to their portfolio in Q1 2025, for an estimated $7,395,980
- MORGAN STANLEY removed 361,834 shares (-66.8%) from their portfolio in Q1 2025, for an estimated $6,114,994
- STATE STREET CORP removed 312,637 shares (-38.2%) from their portfolio in Q1 2025, for an estimated $5,283,565
- D. E. SHAW & CO., INC. added 309,332 shares (+236.7%) to their portfolio in Q1 2025, for an estimated $5,227,710
- VANGUARD GROUP INC removed 223,100 shares (-16.0%) from their portfolio in Q1 2025, for an estimated $3,770,389
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FULGENT GENETICS Government Contracts
We have seen $5,292,914 of award payments to $FLGT over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- GERMLINE PGX MOLECULAR TESTING: $2,849,000
- GERMLINE GENETIC TESTING SERVICES: $2,204,514
- GENETICS TESTING: $190,000
- GENETIC TESTING FOR VA PORTLAND HEALTH CARE SYSTEM: $49,400
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
FULGENT GENETICS Analyst Ratings
Wall Street analysts have issued reports on $FLGT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Outperform" rating on 05/05/2025
To track analyst ratings and price targets for FULGENT GENETICS, check out Quiver Quantitative's $FLGT forecast page.
FULGENT GENETICS Price Targets
Multiple analysts have issued price targets for $FLGT recently. We have seen 2 analysts offer price targets for $FLGT in the last 6 months, with a median target of $24.0.
Here are some recent targets:
- David Westenberg from Piper Sandler set a target price of $23.0 on 05/06/2025
- Andrew Cooper from Raymond James set a target price of $25.0 on 05/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
